Hearty congratulations to our faculty @AnujkumarTvm for receiving a Travel Grant at the International Conference of Head and Neck Oncology (ICHNO) 2024, held in Busan, South Korea for an oral presentation "Impact of RT volumes on patterns of failure in oral cancers with PNI" 🎉🎓
@DrVijayPatil11@pankajch37 @learningonco @VanitaNoronha Yes Sir. In unresectable recurrent nasopharyngeal cancers, results from this study are encouraging, showing an absolute 20 % improvement in 3 year OS
Some caveats, for example late toxicities, may have been lower in the control arm if they used the 1.8 to 2 Gy/# rather than 2.2.
Announcing the AROI - @ESTRO_RT Head & Neck training course 📢📢📢
✅️ 25th - 27th May 2023 @TataMemorial
✅️ Focus on Oral Cavity & PNS tumors
✅️ For Rad Oncs & Med Physicists
✅️ Last date for registration 31st March 2023
✅️ [email protected]
Ph III RCT of 900 resected LA OSCC testing adjuvant treatment intensification with concurrent weekly cisplatin & accelerated RT.
Only a cohort of patients with combination of high-risk features ( T3-4, N 2-3 & ECE+) likely candidates for intensification.
Congratulations HN team!
Vandana Gupta and the amazing team at @vcare24 have been planning to host a @chaiforcancer adda for a while now & how appropriate that it happened today along with the Diwali Puja at the V Care office . It is not just the thought followed up by this thoughtful action but the …
Here's some cheer to brighten your morning ☀️
Our own @AnujkumarTvm has won the Popular Choice Award for Male Voice at the *Doctor Sur Samrat Talent Hunt 2022* conducted by Lupin Pharma & hosted by @singer_shaan!!
Congratulations Anuj! You deserve this and much more 🥳🎉🎊
Authors present impact of 1st wave of #COVID19 on RT practices @TataMemorial@ACTREC_TMC
4256 pts consulted @RadOncTMC between 1st Mar & 31st Oct 2020
Hypofractionation used across disease sites to minimize visits & optimize compliance
Low rates of #COVID19 +vity during RT